Shopping Cart
- Remove All
Your shopping cart is currently empty
Mal-(CH2)5-Val-Cit-PAB-Eribulin is a potent antitumor ADC drug-linker conjugate utilizing Eribulin, an anti-microtubule agent, connected through the Mal-(CH2)5-Val-Cit-PAB linker.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $314 | Backorder | |
| 5 mg | $813 | Backorder | |
| 10 mg | Inquiry | Backorder | |
| 50 mg | Inquiry | Backorder |
| Description | Mal-(CH2)5-Val-Cit-PAB-Eribulin is a potent antitumor ADC drug-linker conjugate utilizing Eribulin, an anti-microtubule agent, connected through the Mal-(CH2)5-Val-Cit-PAB linker. |
| In vitro | Eribulin (E7389) is a microtubule-targeting agent employed in the research of metastatic breast cancer, inhibiting cancer cell proliferation by binding to microtubule proteins and microtubules[2]. |
| Synonyms | Mal-(CH2)5-Val-Cit-PAB-Eribulin |
| Molecular Weight | 1328.565 |
| Formula | C69H97N7O19 |
| Cas No. | 2130869-21-3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.